Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,106 public trials 617 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

NCT01368523

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations: Novartis Investigative Site Gdansk, Poland

Novartis Investigative Site Poznan, Poland

Novartis Investigative Site Warsaw, Poland

View Trial Details

Completed

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

NCT02084563

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +29 more
Locations: Hospital Israelita Albert Einstein São Paulo, Brazil

View Trial Details

Completed

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

NCT00760877

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Novartis Investigative Site Caba, Buenos Aires, Argentina

Novartis Investigative Site St Leonards, New South Wales, Australia

Novartis Investigative Site Westmead, New South Wales, Australia

Novartis Investigative Site Herston, Queensland, Australia

View all 30 locations

View Trial Details

Completed

Trial to Reduce Alloimmunization to Platelets (TRAP)

NCT00000589

Conditions: Blood Platelets, Blood Transfusion, Hematologic Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

NCT01635296

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Valhalla, New York, United States

Philadelphia, Pennsylvania, United States

San Antonio, Texas, United States

Toronto, Ontario, Canada

View Trial Details

Completed

A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

NCT01641250

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Marseille, France

Nantes, France

Paris, France

Toulouse, France

View Trial Details

Completed

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

NCT01396499

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

NCT00691938

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)

NCT00015587

Conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Acute Myelogenous Leukemia, +13 more
Locations: University of California, School of Public Health, Childhood Leukemia Study Berkeley, California, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions